As of June 2026 Theravance Biopharma has a market cap of โน85.78 Billion. This makes Theravance Biopharma the world's 6400th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jun 28th, 2026 the market cap of Theravance Biopharma was reported to be: